Skip header and navigation

Refine By

   MORE

8 records – page 1 of 1.

[Catheterization of the hepatic artery and its associated care]

https://arctichealth.org/en/permalink/ahliterature4257
Source
Kango Gijutsu. 1980 Jun;26(8):22-8
Publication Type
Article
Date
Jun-1980
Author
K. Haida
T. Miura
S. Haida
Source
Kango Gijutsu. 1980 Jun;26(8):22-8
Date
Jun-1980
Language
Japanese
Publication Type
Article
Keywords
Catheterization - methods
Hepatic Artery
Humans
Liver Neoplasms - nursing
PubMed ID
6901817 View in PubMed
Less detail

[Hepatic arterial infusion chemotherapy and hyperthermia with degradable starch microspheres in primary and metastatic liver malignancies]

https://arctichealth.org/en/permalink/ahliterature4162
Source
Gan To Kagaku Ryoho. 1989 Aug;16(8 Pt 2):2822-6
Publication Type
Article
Date
Aug-1989
Author
T. Miura
K. Haida
Author Affiliation
Hanzomon Hospital, Dept. of Surgery.
Source
Gan To Kagaku Ryoho. 1989 Aug;16(8 Pt 2):2822-6
Date
Aug-1989
Language
Japanese
Publication Type
Article
Keywords
Antineoplastic Combined Chemotherapy Protocols - administration & dosage - therapeutic use
Carcinoma, Hepatocellular - blood - therapy
Combined Modality Therapy
Embolization, Therapeutic - methods
English Abstract
Fluorouracil - administration & dosage
Hepatic Artery
Humans
Hyperthermia, Induced
Infusions, Intra-Arterial
Liver Neoplasms - blood - secondary - therapy
Microspheres
Mitomycin
Mitomycins - administration & dosage
Pilot Projects
Starch - administration & dosage
Tumor Markers, Biological - blood
Abstract
In non-resectable liver malignancies, concurrent administration of degradable starch microspheres (DSM) and anticancer drugs via hepatic artery has been suggested as a method to increase the concentration of drugs in tumor tissue. DSM also has been known to increase the temperature of tissue when administered at the time of hyperthermia. In the light of these findings we have studied the effect of hepatic arterial infusion of 5-FU and mitomycin C and local hyperthermia in combination with hepatic arterial flow arrest with DSM for the treatment of hepatoma in 11 patients and metastatic liver cancer in 38 patients. Of the 8 patients having hepatoma with increased AFP, all the patients showed a decrease of AFP following the therapy with an average ratio of 65% decrease. Of the 33 patients with hepatic metastasis with increased CEA, 32 patients (96%) showed a decrease of CEA following the therapy (control group with infusion chemotherapy and hyperthermia without DSM: 58%) with an average decrease ratio of 59% (control group: 43%). Of the 26 patients with increased CA 19-9, 22 patients (84%) showed a decrease of CA 19-9 (control group: 75%) with an average decrease ratio of 52% (control group: 29%). This pilot study suggests that the concurrent hepatic arterial infusion of 5-FU, mitomycin C and DSM with local hyperthermia may have the potential to improve selective regional drug effect.
PubMed ID
2551225 View in PubMed
Less detail

[Hepatic arterial infusion chemotherapy and hyperthermia with degradable starch microspheres in primary and metastatic liver malignancies]

https://arctichealth.org/en/permalink/ahliterature4170
Source
Gan To Kagaku Ryoho. 1988 Aug;15(8 Pt 2):2578-82
Publication Type
Article
Date
Aug-1988
Author
T. Miura
K. Haida
Author Affiliation
Hanzomon Hospital, Department of Surgery, Tokyo, Japan.
Source
Gan To Kagaku Ryoho. 1988 Aug;15(8 Pt 2):2578-82
Date
Aug-1988
Language
Japanese
Publication Type
Article
Keywords
Antineoplastic Combined Chemotherapy Protocols - administration & dosage - therapeutic use
Carcinoma, Hepatocellular - drug therapy - therapy
Combined Modality Therapy
Embolization, Therapeutic - methods
English Abstract
Fluorouracil - administration & dosage
Hepatic Artery
Humans
Hyperthermia, Induced
Infusions, Intra-Arterial
Liver Neoplasms - drug therapy - secondary - therapy
Microspheres
Mitomycin
Mitomycins - administration & dosage
Pilot Projects
Starch - administration & dosage
Tumor Markers, Biological - blood
Abstract
In non-resectable liver malignancies, concurrent administration of degradable starch microspheres (DSM) and anticancer drugs via hepatic artery has been suggested as a method to increase the concentration of drugs in tumor tissue. DSM also has been known to increase the temperature of tissue when administered at the time of hyperthermia. In the light of these findings, we have studied the effect of hepatic arterial infusion of 5-FU and mitomycin C and 2450 MHz microwave local hyperthermia in combination with hepatic arterial flow arrest with DSM for the treatment of hepatoma in 10 patients and metastatic liver cancer in 20 patients. Of the 8 patients with hepatoma with increased AFP, all the patients showed a decrease of AFP following therapy with an average decrease ratio of 64%. Of the 17 patients with hepatic metastasis with increased CEA, 16 patients (94%) showed a decrease of CEA following the therapy (control group with infusion chemotherapy and hyperthermia without DSM: 66%) with average decrease ratio of 50% (control group: 27%). Of the 15 patients with increased CA 19-9, 13 patients (86%) showed a decrease of CA 19-9 (control group: 62%) with an average decrease ratio of 52% (control group: 21%). This pilot study suggests that the concurrent hepatic arterial infusion of 5-FU, mitomycin C and DSM with local hyperthermia may have the potential to improve selective regional drug effect.
PubMed ID
2843126 View in PubMed
Less detail

[Intra-arterial infusion chemotherapy for metastatic liver cancer (author's transl)]

https://arctichealth.org/en/permalink/ahliterature4264
Source
Rinsho Hoshasen. 1979;24(10):1075-82
Publication Type
Article
Date
1979

Renal cell carcinoma of the spindle cell type with metastasis to the pancreas: a case report.

https://arctichealth.org/en/permalink/ahliterature4026
Source
Jpn J Clin Oncol. 1997 Feb;27(1):58-61
Publication Type
Article
Date
Feb-1997
Author
B. Zhao
W. Kimura
N. Futakawa
T. Muto
K. Haida
Author Affiliation
First Department of Surgery, University of Tokyo, Japan.
Source
Jpn J Clin Oncol. 1997 Feb;27(1):58-61
Date
Feb-1997
Language
English
Publication Type
Article
Keywords
Adrenal Gland Neoplasms - secondary
Brain Neoplasms - secondary
Carcinoma, Renal Cell - secondary - surgery
Humans
Kidney Neoplasms - pathology - surgery
Lung Neoplasms - secondary
Lymphatic Metastasis
Male
Middle Aged
Pancreatic Neoplasms - secondary - surgery
Abstract
We report a case of renal cell carcinoma in a 49-year-old man with multiple metastases, including some to the pancreas which were initially diagnosed as primary pancreatic carcinoma. The first clinical manifestation was jaundice caused by a large metastatic lymph node. Computed tomography showed tumors in the body and tall of the pancreas as well as in the left kidney. Angiography showed that all of the lesions were hypervascular. The patient was finally diagnosed as having renal cell carcinoma. Cholecystectomy and choledochojejunostomy were performed. Intraoperative biopsy of the lymph nodes along the common hepatic artery showed spindle cell carcinoma which was compatible with renal cell carcinoma. Since renal cell carcinoma with pancreatic metastasis is rare, special attention should be paid to its differentiation from primary pancreatic carcinoma in patients with tumors in both the pancreas and kidneys.
PubMed ID
9070343 View in PubMed
Less detail

[Study on pulse wave analysis of implanted pacemaker (author's transl)]

https://arctichealth.org/en/permalink/ahliterature5236
Source
Nippon Kyobu Geka Gakkai Zasshi. 1979 Nov;27(11):1552-63
Publication Type
Article
Date
Nov-1979

8 records – page 1 of 1.